Pixium Vision S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
9,420.20
42,131.70
24,353.80
14,244.20
10,531.60
15,629.40
Total Accounts Receivable
1,782.20
2,492.80
2,999.00
2,087.10
2,334.30
1,429.80
Inventories
-
-
-
312.20
909.10
-
Other Current Assets
124.40
241.80
329.40
761.80
106.60
129.80
Total Current Assets
11,326.80
44,866.30
27,682.20
17,405.30
13,881.60
17,189
Net Property, Plant & Equipment
641.00
627.30
2,071.50
1,785.80
1,567.30
706.10
Total Investments and Advances
-
45.80
193.10
193.10
402.20
253.80
Intangible Assets
8,277.50
9,259.10
8,822.40
8,205.40
7,679.60
2,623.30
Other Assets
47.10
-
-
-
287.70
553.30
Total Assets
20,292.30
54,798.50
38,769.10
27,589.60
23,818.40
21,325.50
ST Debt & Current Portion LT Debt
-
-
-
-
1.50
Accounts Payable
1,378.50
1,729.20
2,159.10
1,292.90
1,222.40
Income Tax Payable
14.80
52.30
16.30
12.60
46.90
Other Current Liabilities
643.80
2,269.10
1,322.70
1,530.70
1,481.40
Total Current Liabilities
2,037.20
4,050.60
3,498.10
2,836.20
2,752.20
Long-Term Debt
-
-
-
1,333.40
9,130.50
Provision for Risks & Charges
29.70
77.80
150.80
171.90
171.60
Other Liabilities
-
166.90
164.30
-
-
Total Liabilities
2,066.80
4,295.30
3,813.10
4,341.50
12,054.30
Common Equity (Total)
18,225.50
50,503.20
34,956.00
23,248.10
11,764.10
Total Shareholders' Equity
18,225.50
50,503.20
34,956.00
23,248.10
11,764.10
Total Equity
18,225.50
50,503.20
34,956.00
23,248.10
11,764.10
Liabilities & Shareholders' Equity
20,292.30
54,798.50
38,769.10
27,589.60
23,818.40

About Pixium Vision

View Profile
Address
74, rue du Faubourg Saint-Antoine
Paris Ile-de-France 75012
France
Employees -
Website http://www.pixium-vision.com
Updated 07/08/2019
Pixium Vision SA engages in the development of innovative retinal implant systems specializing in sensory neuromodulation. Its products include Intelligent Retinal Implant Systems and PRIMA system. The IRIS treats patients who have lost their sight through degenerative conditions of the eye such as retinitis pigmentosa, other retinal dystrophies or age-related macular degeneration.